Immune suppression and chemical carcinogenesis.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D001397:Azoxymethane; D001402:B-Lymphocytes / Q000276:immunology; D002273:Carcinogens; D003043:Cocarcinogenesis; D006224:Cricetinae; D006881:Hydroxyacetylaminofluorene; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced*; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology; D013997:Time Factors
D000961:Antilymphocyte Serum; D002273:Carcinogens; D007166:Immunosuppressive Agents; D006881:Hydroxyacetylaminofluorene; D001397:Azoxymethane